Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Prepaid Assets (2019 - 2025)

Historic Prepaid Assets for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $15.8 million.

  • IDEAYA Biosciences' Prepaid Assets rose 2956.02% to $15.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year increase of 2956.02%. This contributed to the annual value of $13.4 million for FY2024, which is 7858.67% up from last year.
  • Latest data reveals that IDEAYA Biosciences reported Prepaid Assets of $15.8 million as of Q3 2025, which was up 2956.02% from $15.9 million recorded in Q2 2025.
  • IDEAYA Biosciences' Prepaid Assets' 5-year high stood at $15.9 million during Q2 2025, with a 5-year trough of $2.8 million in Q1 2022.
  • Its 5-year average for Prepaid Assets is $7.9 million, with a median of $6.7 million in 2023.
  • As far as peak fluctuations go, IDEAYA Biosciences' Prepaid Assets tumbled by 2348.41% in 2022, and later surged by 16283.58% in 2024.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Prepaid Assets stood at $3.1 million in 2021, then surged by 73.36% to $5.4 million in 2022, then soared by 38.53% to $7.5 million in 2023, then surged by 78.59% to $13.4 million in 2024, then rose by 17.67% to $15.8 million in 2025.
  • Its last three reported values are $15.8 million in Q3 2025, $15.9 million for Q2 2025, and $15.4 million during Q1 2025.